Implantable layers for a surgical instrument

Patent metadata

Field	Value
Publication number	US-11058425-B2
Application number	US-201514827932-A
Country	US
Kind code	B2
Filing date	Aug 17, 2015
Priority date	Aug 17, 2015
Publication date	Jul 13, 2021
Grant date	Jul 13, 2021

Abstract

A staple cartridge is disclosed. The staple cartridge can include a cartridge body, a plurality of staples, and an implantable layer. The implantable layer can include a piece of lyophilized foam and a plurality of fibers at least partially embedded in the piece of lyophilized foam. The implantable layer can further include a plurality of pores defined in piece of lyophilized foam, and a plurality of pockets, wherein a pocket at least partially surrounds a fiber. A method of forming an implantable layer for use with a surgical staple is also disclosed. The method can comprise obtaining a mold comprising a cavity, placing a plurality of fibers in the cavity of the mold, dispensing a solution into the cavity around the fibers, and lyophilizing the solution in the cavity.

First claim

What is claimed is:

1. A staple cartridge, comprising:
a cartridge body comprising a plurality of staple cavities;
a plurality of staples removably positioned in said staple cavities; and
a biocompatible implantable layer, comprising:
a piece of lyophilized foam; and
a frame comprising a plurality of fibers at least partially embedded in said piece of lyophilized foam before an implantation of said biocompatible implantable layer, wherein said fibers are configured to repel said lyophilized foam to form passages which are oriented at various angles to facilitate tissue ingrowth.

2. The staple cartridge of claim 1 , wherein said biocompatible implantable layer comprises:
a plurality of pores defined in said piece of lyophilized foam; and
a plurality of pockets, wherein a said pocket at least partially surrounds a said fiber.

3. The staple cartridge of claim 2 , wherein said plurality of pockets comprises:
a first pocket; and
a second pocket transecting said first pocket.

4. The staple cartridge of claim 1 , wherein said fibers are randomly oriented throughout said piece of lyophilized foam.

5. The staple cartridge of claim 1 , wherein said fibers comprise an ordered matrix of fibers in said piece of lyophilized foam.

6. The staple cartridge of claim 1 , wherein said fibers comprise:
a first fiber comprising a first geometry; and
a second fiber comprising a second geometry, wherein said second geometry is different than said first geometry.

7. The staple cartridge of claim 1 , wherein said fibers comprise:
a first fiber comprising a first material; and
a second fiber comprising a second material, wherein said second material is different than said first material.

8. The staple cartridge of claim 1 , wherein said piece of lyophilized foam comprises a first absorption rate, wherein at least one said fiber comprise a second absorption rate, and wherein said second absorption rate is different than said first absorption rate.

9. The staple cartridge of claim 1 , wherein said biocompatible implantable layer comprises a tissue-contacting surface, and wherein at least one said fiber extends to said tissue-contacting surface.

10. The staple cartridge of claim 1 , wherein said lyophilized foam comprises a hydrophilic coating to attract water and increase cell adhesion.

11. The staple cartridge of claim 1 , wherein said lyophilized foam comprises polyglycolic acid.

12. The staple cartridge of claim 1 , wherein said lyophilized foam comprises polycaprolactone.

13. The staple cartridge of claim 1 , wherein said lyophilized foam comprises a combination of polyglycolic acid and polycaprolactone.

14. The staple cartridge of claim 1 , wherein said plurality of fibers are interwoven.

15. A staple cartridge, comprising:
a cartridge body comprising a plurality of staple cavities;
a plurality of staples removably positioned in said staple cavities; and
a biocompatible implantable layer, comprising:
a frame comprising a plurality of fibers;
a porous foam comprising a plurality of pores; and
a plurality of tissue ingrowth pockets defined between portions of said porous foam as said fibers repel said foam, and wherein said plurality of tissue ingrowth pockets define passages which are oriented at various angles within said biocompatible implantable layer.

16. The staple cartridge of claim 15 , wherein some of said plurality of fibers are at least partially embedded in said porous foam.

17. The staple cartridge of claim 16 , wherein said tissue ingrowth pockets at least partially surround said fibers.

18. The staple cartridge of claim 16 , wherein said foam encases said fibers.

19. The staple cartridge of claim 15 , wherein said porous foam comprises a hydrophilic coating to attract water and increase cell adhesion.

20. The staple cartridge of claim 15 , wherein said porous foam comprises polyglycolic acid.

21. The staple cartridge of claim 15 , wherein said porous foam comprises polycaprolactone.

22. The staple cartridge of claim 15 , wherein said porous foam comprises a combination of polyglycolic acid and polycaprolactone.

23. The staple cartridge of claim 15 , wherein said plurality of fibers are interwoven.

Assignees

• Ethicon Endo Surgery Llc
• Ethicon Llc

Inventors

• Widenhouse Christopher W
• Miller Michael J
• Timmer Mark D
• Aronhalt Taylor W
• Barton Trevor J
• Schellin Emily A
• Vendely Michael J
• Weaner Lauren S
• Sikes Courtney J

Classifications

• A61B17/07292 Primary

  Reinforcements for staple line, e.g. pledgets · CPC title

• A61B2017/00884

  enhancing wound closure · CPC title

• B29C44/3415

  Heating or cooling · CPC title

• A61B2017/00526

  Methods of manufacturing · CPC title

• A61B2017/00964

  composite · CPC title